Nano Science Diagnostics Inc.

Rajendra Pratap Gupta (Rajendra) is a Global Healthcare thought leader. He is an advisor to the World Health Care Congress – USA & Europe, sits on a five member international Task Force of DMAA, USA and a Director, DMAA- The Care Continuum Alliance, USA. He is also the founding president of Disease Management Association of India

Rajendra has been known for his in depth understanding of public systems across sectors, and was the co-author of the manifesto of one of the largest political parties in India for Lok Sabha Elections in 2009. He is amongst the core group of international experts invited from 13 countries by the PHFI to deliberate and discuss the health systems agenda for India and make recommendations for transformation of the India’s healthcare system. PHFI is founded by the current Prime Minister of India, Dr. Manmohan Singh in 2006.

He has also served on the CII sub-committee for Private Public relationships for Healthcare & is also on the Executive Council of the Telemedicine Society of India
Rajendra has been recognised globally for promoting preventive care and chronic care management .He became the first person from Asia-Pacific to be nominated to the prestigious board of the DMAA- The Care Continuum Alliance, Washington, DC.

Rajendra has worked in leadership role for fortune 20 & fortune 500 companies in India . He is the former Chief Operating Officer & Member of the Board at Medicine Shoppe Intl Inc. – India & Head of Retail & Supply Chain of Reliance ADAG – Healthcare & Chief Executive Officer & A Member of the Board at Medybz Pvt Ltd.– A Disease Management company of the Reliance ADAG .

He has executive education from IIM-A, Kellogg School of Management and Harvard Business School, USA . He writes for international journals and magazines and is a much sought after speaker in national and international forums. Currently, Rajendra serves at the board & Advisory level in USA, Europe , Africa , Middle East & India across sectors like retail , healthcare , hospital chains , pharmacy chains , disease management , diagnostics , pharmaceutical R&D, Dermo- cosmetics , telemedicine companies .